109
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Effect of long-term 50 Hz magnetic field exposure on the micronucleated polychromatic erythrocytes of mice

, , , &
Pages 51-57 | Received 25 Jul 2012, Accepted 10 Jan 2013, Published online: 19 Jun 2013
 

Abstract

In recent years extremely low-frequency magnetic fields (ELF-EMF) have become widely used in human activities, leading to an increased chance of exposure to ELF-EMF. There are few reports on in vivo mammalian genotoxic effects using micronucleus (MN) assays, which generally have been used as a short-term screening system. We analyzed the possible genotoxic effect induced by long-term exposure (7, 14, 21, 28 d) of a 50 Hz ELM-MF to mice by measuring the increase in frequency of micronucleated polychromatic erythrocyte in their bone marrow (MNPCEs) and we compared it with that induced by 50 cGy of X-rays. Subsequently, we tried to reduce this chromosomal damage by administering four antioxidants substances with radioprotective capacities: dimethyl sulfoxide (DMSO), 6-n-propyl-2-thiouracil (PTU), grape-procyanidins (P) and citrus flavonoids extract (CE). The increase in micronucleated cells was higher in both physical treatments (Control < ELF-EMF (p < 0.01) <X-rays (p > 0.001)); however, the antioxidant substances only showed a genoprotective capacity against the damage induced by ionizing radiation (Ci > PTU = DMSO (p < 0.001) >P = CE (p < 0.001). The 50 Hz ELM-MF increased MNPCEs in mouse bone marrow, expressing a genotoxic capacity. Administration of antioxidant substances with radioprotective capacities known to act through the elimination of free radicals did not diminish the genotoxic effect induced by ELM-MF.

Acknowledgements

Configuration and control measurements of the magnetic field exposure were carried out by Prof. J. Margineda, Head of Department of Electromagnetism and Electronics of Faculty of Physics; and the statistical study was performed by Prof. M. Canteras, Head of the Department of Biostatistics of the Faculty of Medicine, both of the University of Murcia, Spain.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.